Du, S., Zeng, S., Song, L., Ma, H., Chen, R., Luo, J., Wang, X., Ma, T., Xu, X., Sun, H., Yi, P., Guo, J., Huang, Y., Liu, M., Wang, T., Liao, W.P., Zhang, L., Liu, J.Y., Tang, B. (2023). Functional characterization of novel NPRL3 mutations identified in three families with focal epilepsy.  Sci. China Life Sci. 66(9): 2152--2166.

FBrf0257567

Research paper

Focal epilepsy accounts for 60% of all forms of epilepsy, but the pathogenic mechanism is not well understood. In this study, three novel mutations in NPRL3 (nitrogen permease regulator-like 3), c.937_945del, c.1514dupC and 6,706-bp genomic DNA (gDNA) deletion, were identified in three families with focal epilepsy by linkage analysis, whole exome sequencing (WES) and Sanger sequencing. NPRL3 protein is a component of the GATOR1 complex, a major inhibitor of mTOR signaling. These mutations led to truncation of the NPRL3 protein and hampered the binding between NPRL3 and DEPDC5, which is another component of the GATOR1 complex. Consequently, the mutant proteins enhanced mTOR signaling in cultured cells, possibly due to impaired inhibition of mTORC1 by GATOR1. Knockdown of nprl3 in Drosophila resulted in epilepsy-like behavior and abnormal synaptic development. Taken together, these findings expand the genotypic spectrum of NPRL3-associated focal epilepsy and provide further insight into how NPRL3 mutations lead to epilepsy.